The overall cancer mortality rate in the United States has continued its year-to-year decline, according to new statistics released by the American Cancer Society. The overall U.S. cancer mortality rate has now decreased 31% between 1991 and 2018.
The pace of approving promising new greatments doesn't appear to be slowing. In these first days of the new year, FDA approved a new therapy that can be used for earlier stage NSCLC patients, and granted breakthrough therapy designation to a new immunotherapy drug. Read about the newest approvals and see the dramatic progress in treatment approaches over the years.
LCRF awarded $1.2 million dollars in research grants to eight investigators whose projects show promise to make a sustained and lasting impact on the field of lung cancer research and lung cancer outcomes. Read more about the awards and meet our current grantees.
Kathy Meyer beat the odds after being diagnosed with SCLC, and her family treasures the 13 years they were given before Kathy passed away from COVID-19 complications 9 months ago. Her daughter Kimberly shares what that time means to her.
The first virtual Free to Breathe Walk on Oct. 3, 2020 wouldn't have had the impact it did without all the individuals and teams who raised funds so research could continue during a very challenging year. A big thank you! See our top fundraising teams here.
...the experts who generously gave their time to our #TogetherSeparately live talks the last half of 2020: Amy Scharmer, Doreen Schultz, Jayme Bowles, Dr. Joan Schiller, Dr. Narjust Duma, Dr. Ibiayi Dagogo-Jack, Rev. Miriam J. Burnett, and Dr. Alice Berger
...our 2020 slate of grantees – we couldn't be more proud to be part of the important work they're doing!